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Abstract 
Objectives: The number of systematic reviews of nursing interventions is increasing 
in China. Authors of such studies are encouraged to use a risk of bias tool for 
assessing individual studies. Therefore, it is important to know how these tools have 
been applied in systematic reviews in Chinese nursing.  
Methods: To examine risk of bias tools used by Chinese nursing researchers to assess 
the quality of individual studies included in systematic reviews of nursing 
interventions. We searched the Chinese Biomedical Literature Database; Chinese 
Journal Full-text; Chinese Academic Journal Full-text Database; and Wanfang 
Database. Each relevant review found was subjected to quality assessment, data 
synthesis and comprehensively described.  
Results: 208 systematic reviews were identified, most (94.7%) of which used the 
words ‘systematic review’ or ‘meta-analysis’ in their titles. Most used quality 
assessment rather than risk of bias as their major method to gauge quality; 7.6% 
reported on six domains of the Cochrane risk of bias tool. Only four provided a risk of 
bias graph/summary figure.  
Conclusions: Many systematic reviews of nursing interventions are published in 
Chinese journals, and their assessment of risk of bias is usually either lacking or 
incomplete, potentially producing misleading results. This may also be the case in 
other countries. Assessment of risk of bias in systematic reviews is a requisite. 
Authors who systematically review nursing literature should follow the latest 
Cochrane Collaboration Handbook.  
Key words: Systematic reviews; Chinese Journals; Risk of bias 
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INTRODUCTION 
Evidence-based practice (EBP) in nursing is important in all countries, and has 
become increasingly so in China. As a way of summarizing research evidence on a 
specific question, systematic reviews (SRs) use explicit, systematic methods that are 
selected with a view to minimizing bias, thus providing more reliable findings for 
professional practice [1]. The methodological quality of studies included in a 
systematic review can have a substantial impact on the estimates of the treatment 
effect and therefore on the conclusions of such a review [2]. Since inclusion of less 
robust studies can lead to unreliable, often inflated estimates of treatment effects[3], a 
key element in the SR process is appraisal of the risk of bias or methodological 
quality of the constituent primary studies to decide whether their results can be trusted 
and should contribute to eventual meta-analyses[4].  
Randomised controlled trials (RCTs), the “gold standard” for experimental study 
design, and SRs of such trials constitute the highest level of evidence; they are also 
the key in the practice of evidence-based medicine [1]. However, RCTs are often 
inadequately reported and may be inadequately conducted [5]. It is therefore 
important, in order to minimize bias in the conclusions of a SR, to consider potential 
limitations of each included RCT. 
 
BACKGROUND 
With the growth in the number of published nursing SRs in Chinese journals, it is 
imperative that reviewers understand how to evaluate and critique the internal validity, 
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risk of bias, or methodological quality of RCTs included in SRs in order to identify 
limitations of individual studies and to obtain reliable evidence [6].  
Risk of bias, defined as the risk of “a systematic error or deviation from the truth, 
in results or inferences” [7] is interchangeable with ‘internal validity’, which is 
defined as “the extent to which the design and conduct of a study are likely to have 
prevented bias” [8]. The Grading of Recommendations Assessment, Development and 
Evaluation Working Group (GRADE) describes quality assessment as judgments 
based on the strength of the evidence [9]. The Cochrane Collaboration argues for 
wider use of risk of bias tools instead of quality assessment, as the implementation of 
risk of bias assessment reduces possible ambiguity between the quality of the research 
itself and the quality of its reporting [1].  
The internal validity of a RCT study can be influenced by selection bias, 
performance bias, detection bias, attrition bias, reporting bias, and other biases during 
the research process [9]; therefore, there are many tools developed for assessing the 
“?risk of bias““of the studies. Olivo et al. [7] identified 105 relevant studies which 
accounted for 21 tools used in the evaluation of methodological quality of RCTs. Of 
these, most are scales, in which various components of quality are scored and 
combined to give a summary score[6]. Many of these scales had not been rigorously 
developed or tested for validity and reliability; this was also found in Moher et al’s 
study where the scales demonstrated a lack of any theoretical basis. They also varied 
in respect of their size, complexity, and the weight attributed to individual 
methodological aspects such as randomization procedures or blinding[10]. Of these 
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tools, the Jadad scale, developed in pain research in 1996 to assess the quality of 
RCTs [11], was the most commonly used tool in SRs. Since a single score of trial 
quality is obviously appealing, this scale seems easier to interpret than a series of ticks 
on a checklist. However, the scale does not cover one of the most important potential 
biases in randomized trials, namely allocation concealment[11].  
Another, the Critical Appraisal Skill Program (CASP) checklist for RCTs, 
developed in Oxford in 1993, comprises 11 items [12] and is recommended for new 
researchers and those who wish to have quick, simple, and easy-to-understand tools 
for answering common questions[13].  
The Quality Assessment of Diagnostic Accuracy Studies (QUADAS) was first 
developed in 2003 for the quality assessment of studies of diagnostic accuracy, and 
has four domains which are scored for risk of bias assessment [14]. QUADAS-2, an 
improved tool, was developed in 2015[15]. Although many tools exist, they are being 
used inconsistently across the RCTs. Such inconsistency should be discouraged as 
results and conclusions may differ depending on the type of scale or checklist used.   
The Cochrane Collaboration is an international network aiming to produce and 
publish credible and accessible health information. Cochrane reviews are recognized 
globally as being SRs of the highest standard in evidence-based health care[16]. For 
Cochrane SRs, high methodological standards have been developed to ensure high 
quality and consistent review development and reporting[17]. 
In 1994, one of the first editions of the Cochrane Collaboration Handbook 
recommended that reviewers should routinely assess the adequacy of allocation 
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concealment [1]. In 2005, the Cochrane Collaboration initiated the development of a 
new strategy for assessing risk of bias in RCTs. Pairs of individual researchers wrote 
the first draft of different components of the tool. The original version was first 
published in 2008 in the Cochrane Handbook for Systematic Reviews of 
Interventions[18] and imcuded in the Collaboration’s review-writing software, 
Review Manager 5.0[19]. In 2011 a revised version of the tool split blinding into 
'blinding of participants and personnel' and 'blinding of outcome assessment'[20].  
The Cochrane risk of bias tool has six domains: sequence generation, allocation 
concealment, blinding, incomplete outcome data, selective outcome reporting, and 
other sources of bias. Each domain is assigned a judgment with ‘high’, ‘low’, or 
‘unclear’ risk of bias. A final overall assessment within or across studies is based on 
the responses to individual domains[18].  
The Cochrane risk of bias tool provides a standardized approach and the 
Cochrane Collaboration strongly encourages all reviewers to use the latest tool to 
assess the internal risk of bias of RCTs included in SRs[21]. However, an 
investigation of SRs written about the epidemiology of chronic disease showed only 
55% of the reviews referred to quality assessment of primary studies overall[22].  
Most authors of reviews tend to be reluctant to designate an overall risk of bias 
for each trial or outcome and also are reluctant to incorporate the risk of bias 
assessment in analyses and conclusions[22]. We identified other studies that focused 
on use of a risk of bias tool. While most of these studies evaluated their influence in 
specific fields, such as persistent asthma treatment[23], pediatrics[24], dentistry[25], 
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and acupuncture[26], other studies have assessed inter-rater agreement[27,28]. Some 
reviews have contrasted the Cochrane risk of bias tool with other tools, such as the 
Jadad scale[23].  
Other reviews of SRs and meta-analyses (MAs) published in Chinese journals 
have identified problems with methodological or reporting quality[29,30]. However, 
these studies failed to evaluate the use of the Cochrane risk of bias tool, and there are 
limited published data focusing on how this tool is used when carrying out SRs. We 
identified one study which evaluated the use of risk of bias tools in SRs of 
acupuncture in Chinese journals[31]. 
Correctly choosing the applicability of the risk of bias tools is very important, 
therefore, the purpose of our study was to evaluate whether and to what extent the 
Cochrane recommended risk of bias tool has been used in SRs of nursing 
interventions published in China. Objectives of the evaluation were to: 1) assess the 
use of the Cochrane risk of bias tool; 2) identify factors associated with risk of bias 
assessments; 3) identify additional training requirements. 
METHODS     
Inclusion Criteria 
Systematic reviews of RCTs published in Chinese journals (written in Mandarin 
Chinese) whose primary purpose was to ascertain the effectiveness of nursing 
interventions were included.  
We defined SRs as reviews of a clearly formulated question that use systematic 
and explicit methods to identify, select and critically appraise relevant research, and to 
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collect and analyze data from included studies.  
Meta-analysis within a SR refers to the use of statistical techniques to integrate 
and analyze the results of included studies [1]. We defined ‘nursing intervention’ as 
patient care activities performed by registered nurses focused on improving health.  
For inclusion, the nursing interventions had to have been administered without 
other interventions. We placed no limitations on the types of intervention, study 
population, or clinical setting. Publications which were not labeled as systematic but 
included an explicit statement of search methods, inclusion and exclusion criteria, and 
data synthesis were included as well. 
 
Exclusion criteria 
We excluded SRs which included studies other than RCTs, all types of primary 
studies, and SRs in fields other than nursing.   
Studies which assess methodological quality and reporting quality of the reviews  
were excluded. Methodological quality is defined as “the confidence that the trial 
design, conduct, and analysis have minimized or avoided biases in its treatment 
comparisons.” Reporting quality is defined as “the provided information about the 
design, conduct and analysis of the trial.”[10]. 
 
Search Strategy  
We searched four Chinese databases: Chinese Biomedical Literature Database 
(CBM) from 1978 to December 2015[32], Chinese Journal Full-text Database (CJFD) 
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from 1994 to December 2015 [33], Chinese Academic Journal Full-text Database 
(CSJD) from 1989 to December 2015 [34], and the Wanfang Database from 1998 to 
December 2015 [35].  
The main search terms included ‘systematic review’, ‘meta-analysis’, ‘nursing 
intervention’, ‘nursing’, ‘nurse’ (Fig. 1). The reference lists of retrieved articles were 
searched.  
In order to compare use of the Cochrane risk of bias tool and to find any 
differences when reporting six domains in the tool, we compared our findings with the 
findings in Hopewell’s study[21] which assessed the reviews published in Cochrane 
and Non-Cochrane journals. Also with the findings in Liu’s study[31] which assessed 
the SRs of acupuncture in Chinese journals.   
 
Screening 
Two trained researchers (ZJX, WJC) independently screened the title and abstract 
of each article, and subsequently assessed the potential for inclusion of reviews. If 
consensus could not be reached,  disagreement was solved by discussion or by resort 
to a third reviewer (HL) who holds a PhD in nursing and has had experience in data 
screening.  
 
Data extraction  
Two trained researchers (ZJX, WJC) independently extracted the data that 
included publication characteristics: the design of the studies in the SRs, funding, as 
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well as items from the risk of bias tool: name and version of assessment of bias? tool, 
risk of bias graph/summary, randomization sequence, allocation concealment, 
blinding, incomplete outcome data, and selective reporting.  
The reviewers received training on the evaluation of domains in the Cochrane 
risk of bias tool. The training, provided by the second author (WJC) who holds PhD 
from the Evidence-based Medicine Center of Lanzhou University, covered how 
sequence generation, allocation concealment, and blinding were used; if there were 
incomplete outcome data, selective outcome reporting, and other sources of bias in 
studies and how to judge them. 
After each reviewer completed the data extraction individually, the two reviewers 
met to record their data. Any discrepancy was solved by discussion. Since the first SR 
of RCTs in Chinese nursing was published in 2004, we classified the reviews into two 
groups according to publication years: Group 2004-2008 and Group 2009-2015. 
These years were chosen because, although the Cochrane risk of bias tool was first 
published in February 2008 (Cochrane Handbook 5.0.0), we assessed the use of the 
tool in reviews published before 2009 and after 2008. This gave an indication of the 
use of the Cochrane tool in Chinese nursing since its release.  
 
Analysis 
Data were entered into Excel 2003, and then imported into SPSS 19.0. 
Descriptive analysis (frequency, percentage) was used to summarize the 
characteristics of included SRs. Six domains from the Cochrane risk of bias tool were 
used to evaluate the compliance of each review of quality assessment of included 
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studies. To indicate the degree of compliance, each item was assigned to one of two 
responses: ‘Yes’ (described in papers) for total compliance, and ‘No’ (not described in 
papers) for noncompliance. For statistical purposes, we derived a numeric score for 
the final grade by counting the number of ‘yes’ answers obtained from each study.  
We used Chi-square in a subgroup analysis of total compliance in each domain of 
the Cochrane risk of bias tool. The elements of subgroup analysis were presented as 
the year of publication (≤2008 vs.≥2009). Statistical significance was set at p<0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flowchart of articles identified, included and excluded. 
 
RESULTS 
Review selection 
The initial search yielded 1450 SRs; of these, 1170 records were excluded due to 
208 included studies 
72 studies assessing methodological 
and reporting quality excluded 
1450 citations retrieved from search 
    CSJD =530    CBM=358 
    WF=157       CJFD =405 
1170 excluded after screening titles and 
abstracts 
Dublication(173) Duplication 
Non-nursing intervention SRs (883) 
Non-SRs (114) 
280 full text articles retrieved 
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duplication, a focus on non-nursing interventions, or for not being a SR. After 
examination of the full texts of 280 articles, a further 72 records were excluded 
because they were methodological and reporting quality assessments of SRs. A total 
of 208 publications were included for full data extraction (Fig. 1).  
 
Descriptive characteristics of included SRs/MAs (Table 1) 
The 208 SRs were published in 44 different Chinese journals. Of these, 26.4% 
included ‘‘systematic review’’ and 68.3% included ‘‘meta-analysis’’ in their titles. 
Some of the reviews (5.3%) included evidence-based nursing analysis in their content, 
but did not mention anything about SR or MA in their titles, and were later identified 
as SRs. The reviews were classified as psychological interventions (8.6%), health 
education (15.4%) and nursing skills (76%). The most common conditions studied 
were diseases of the circulatory system (21.6%) and pregnancy, childbirth and the 
puerperium (16.8%). Only 16.8% of the reviews were published in the journals cited 
by the Chinese Science Citation Database (CSCD). The number of studies that each 
SR included ranged from one to 41 (median 11). The SR that included only one RCT 
was a study on health intervention for elderly people with fatty liver disease, which 
was published in the Journal of Nurses Training in 2007.   
 
Tools to measure methodological quality/risk of bias  
2004-2008 group 
Of the 23 reviews before 2009, 21 assessed the quality of the included studies. 
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Among them, nearly one-third used the Cochrane Handbook. Another nine of the 23 
used the Jadad scale to measure methodological quality, while only one used 
QUADAS. Three of the 23, however, failed to assess the risk of bias of included 
studies (Table 2). Hopewell’s study [21] of non-Cochrane reviews examined how 
assessments of risk of bias of primary studies in SRs of RCTs are currently carried out 
and the methods used, but had the same problems (Table 3).  
 
2009-2015 group 
Of the 185 reviews after 2008, 44.3% used the Cochrane Handbook as an 
assessment tool with ten using Version 4[36], and 13 used Version 5 [37]. This is 
significantly different between the two groups (p<0.05). Almost a quarter (21.6%) 
used the Cochrane Handbook but failed to report the exact version. The Jadad scales 
were used by 59 of the 185 reviews, while only two used QUADAS; however, 21 of 
the 185 did not use any tool for quality assessment of included studies (Table 2). 
Compared to our study, 95% of the Cochrane reviews in Hopewell’s study[21] used 
the Cochrane Handbook, while 27% non-Cochrane reviews did so (Table 3).   
 
Assessment of six domains in Cochrane risk of bias tool  
Among the 185 reviews after 2008, 74.6% assessed sequence generation, 64.8% 
allocation concealment, while 100% of the Cochrane reviews and 60% of the 
non-Cochrane reviews did so (Table 5). Of the 185 reviews, 132 assessed blinding 
and 70 loss-to-follow-up; however, the intention-to-treat (ITT) analysis, a component 
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of the incomplete outcome data domain in the Cochrane risk of bias tool, was used in 
only 28 of the 185 published reviews. Twenty-two reported other potential sources of 
bias, and 17 checked for selective outcome reporting (Table 4).  
Most reviews used ‘‘quality assessment’’ rather than ‘‘risk of bias assessment’’ in 
their methods, results or discussions. Only two reviews specified a ‘‘risk of bias tool’’, 
while 7.6% reported on all six domains of the risk of bias tool. Less than half (39.8%) 
gave information on baseline similarities or comparability. A ‘‘risk of bias 
graph/summary’’ figure was provided in only four reviews. Most (73.3%) reported the 
summary scores or grades of the included studies; 14 of these, however, failed to 
show the assessment process used. Three introduced the quality assessment of the 
included studies in their methods section, but failed to report any quality results in 
their results and discussion sections (Table 4).  
 
DISCUSSION 
While the first SR addressing the effectiveness of nursing interventions was 
published in a Chinese journal in 2004 [38], in recent years, there has been an 
increase in the number of nursing intervention reviews in Chinese journals. We 
searched Chinese and English databases, and found that there is limited study on the 
evaluation of risk of bias tools in nursing reviews. Our study is the first to evaluate the 
Cochrane tool in nursing reviews.  
Since the internal validity of a study reflects the extent to which the design and 
conduct of the study have minimized the impact of bias [18], one of the key steps in a 
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SR is the assessment of internal validity (or risk of bias) of studies included for 
evidence synthesis. Since 2008, Cochrane reviews have been expected to include a 
detailed assessment of bias for included studies using the Cochrane risk of bias tool. 
However, in Chinese nursing journals, we found that the evidence from SRs may not 
always be of the highest methodological rigor, as the review authors might not have 
properly assessed risks of bias in their included studies. This problem may also exit in 
other fields, and the authors of non-Cochrane reviews showed the same deficiency. 
The assessment tools used by Chinese nursing reviewers included Cochrane 
handbooks 4 [36] and 5 [37], the Jadad scale [2], QUADAS [14] and the Oxford 
Critical Appraisal Skills Program (CASP) (Table 6)[12]. This is similar to 
Deschartres' study [39], which found that a large number of tools have been used to 
assess the quality of RCTs included in SRs. For Chinese nursing reviews, the 
Cochrane risk of bias tool and Jadad scale were commonly used, and as indicated by 
its citations, Jadad scale continued to be used commonly after the release of the 
Cochrane tool. This is consistent with Armijo [28] who found that the Jadad scale was 
the tool commonly cited in the medical literature. However, the scale was used only in 
7% of the Cochrane systematic reviews [21]. As a tool to assess the quality of an 
individual study, summarized Jadad scores could be useful, especially for those who 
may not have sufficient knowledge to make judgments about quality based on 
individual items. Most importantly, nurses who apply evidence in clinical practice 
need to have a simple method to evaluate the quality of evidence. The Jadad scale 
addresses randomization, blinding, and handling of withdrawals and drop-outs. 
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Although it is a commonly used tool to assess the risk of bias, our study found that 
most reviews reported the final scores but failed to provide detailed information on 
randomization, blinding, and handling of withdrawals and drop-outs, thereby 
demonstrating that the Jadad scale may not provide the most comprehensive measure 
of methodological quality[11]. 
The Cochrane Handbook, which included the Cochrane risk of bias tool, is the 
most commonly used by Chinese nursing authors. This is consistent with Liu’s study 
[31], which indicated that since its release, the six domains included in the tool had 
been frequently used to assess individual characteristics of studies and the Chinese 
reviewers are eager to use latest tools to conduct SRs. However, the application of 
those domains has not improved as no significant differences were found before and 
after 2008. 
The application of most of the individual items in the Cochrane six domains 
increased over the time span, but no statistical differences were shown before and 
after 2009. Up until 2015, the usage of some items in the six domains was still low. 
Although it was well known that only unknown allocation schedules could minimize 
selection bias [1], few SRs in our study reported detailed information on the methods 
used to generate the random allocation sequence and the allocation concealment 
mechanism, while all of the Cochrane reviews in Hopewell’s study[21] did so. In our 
study, they simply used the term “randomization”, possibly leading to lack of clarity 
in evaluating sequence generation and allocation concealment in individual studies. 
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This is consistent with Esposito’s study in which 70% of RCTs published in implant 
dentistry did not describe how randomization and allocation concealment were 
performed [40]. These associated biases could have a serious impact on the findings 
and conclusion of a SR. As some of the included SRs in our study had a single author, 
it is difficult to understand how quality assurance processes were carried out (or not), 
as data extraction and other processes in a SR require at least two authors to ensure 
independence [1]. Consequently, such lack of independence could distort results. This 
demonstrates that nursing reviewers, as well as nursing journal editors in China, pay 
little attention to the methodological quality or risk of bias of studies included in a SR. 
Integration of the GRADE tool in SRs necessitates the consideration of risk of bias in 
rating the strength of evidence and ultimately recommendations for practice [9].      
With ‘unclear’ given as assessment of sequence generation, allocation 
concealment, and overall assessment of risk of bias in SRs, the question arises as to 
how best to assess SRs. As a consequence, it is difficult to understand how such SRs 
could provide reliable evidence for nurses. Hartling’s study [27] found that in 
evaluating the inter-rater agreement of the risk of bias tool, the ratings for many 
domains were deemed “unclear”. This may reflect the nature of the domain or the 
insufficient reporting of the individual study. While reporting may improve as authors 
adopt the consolidated standards of reporting trials (CONSORT) [41] guidelines in 
writing articles, SRs will continue to face issues arising from poor reporting when 
they include studies without following the guidelines. 
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 The poor use of evaluation for quality and risk of bias in included studies in the 
reviews we assessed may have occurred because nursing reviewers may not be aware 
of this requirement, or that the journals that published the SRs we studied had no such 
requirements for submissions. Although a number of articles have been published in 
China on conducting systematic reviews and use of quality assessment and risk of 
bias tools, such as the series of articles on conducting systematic reviews[42], using 
Cochrane risk of bias tool in SRs of RCTs[43], and quality assessment in SRs of 
RCTs[30], there are few particular submission requirements for SRs. An exception is 
the Chinese Journal of Evidence-based Medicine in which authors are required to 
adopt the Preferred Reporting Items of Systematic Reviews and Meta-Analyses 
(PRISMA) guideline when reporting SRs[44]. In the guideline, assessment and 
reporting of risk of bias of individual studies included in SRs are required. 
Evidence-based medicine theory, method and high quality evidence in China are 
exchanged and disseminated mainly in three Chinese journals -the Chinese Journal of 
Evidence-based Medicine, the Journal of Evidence-based Medicine, and the Journal 
of Evidence based Pediatrics. Among them, the Chinese Journal of Evidence-based 
Medicine, the official journal hosted by the Chinese Cochrane Center, and the papers 
published in it, to a certain extent, can reflect the scientific level of Chinese evidence 
based medicine. Zhou WW’s study showed that 91.31% of 379 SRs published in the 
Chinese Journal of Evidence-based Medicine evaluated the risk of bias of individual 
studies[30]. 
 It appears that 80% of the papers published in the journals without reporting 
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guidelines had problems in designation and reporting[45]. If evidence from lower 
quality articles is applied in clinical practice, this will, in conjunction with 
unconfirmed research findings, mislead readers and consequently nursing practice. 
Without appropriate training, most nurses may have poor knowledge about the 
processes of a SR. Some studies showed that nurses knew the term ‘evidence-based 
nursing (EBN)’ but had poor knowledge and practice skills in conducting SRs [46, 47]. 
Such misunderstanding, too, may contribute to poor methodological quality of SRs.  
Journals which attract a high impact factor usually have specified and rigorous 
requirements for submissions, and studies have revealed that reporting of clinical trial 
details tends to be more comprehensive in higher impact journals[48]. However, only 
a few reviews included in our study were published in journals that had an impact 
factor or were indexed by CSCD, that is, Chinese SCI. Assessment of the risk of bias 
of studies included in a SR is a key step in identifying the strengths of individual 
studies. Authors are encouraged to use the latest version of Cochrane Handbook to 
report SRs, and suggest that Chinese journals should have step-by-step specific 
requirements for authors to follow in submitting manuscripts of SRs, for example, the 
PRISMA checklist[44]. Such will help to improve the quality of SRs from the 
beginning.
With a growing interest amongst nurses in EBN, it is clear that nurses should 
incorporate the necessary knowledge, skills and attitudes of EBP into their education, 
training and registration requirements. Continuing professional education can improve 
knowledge, but it has been demonstrated that workshops on critical appraisal had 
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improved knowledge but not the evidence-seeking behavior of health 
professionals[49,50]. Therefore, a major challenge for educators is effecting 
knowledge transfer and behavior change.  
What appears to help promote behaviour change is partly the way in which 
education is delivered, and partly the provision of follow-up[49].We recommend that 
researchers investigate components of workshops that contribute to effectiveness, 
such as practicing skills during and after a workshop, providing follow-up outreach 
support, and providing feedback to encourage behavior change. In universities, the 
curricula for students should be based on the five EBP steps and processes: asking 
clinical questions, searching for and appraising research evidence, integrating the 
evidence into clinical practice and evaluating this process[51] to ensure that future 
nurse graduates learn how to incorporate EBP steps with their own life-long learning 
and patient care. National and international research should evaluate culturally 
specific implementation strategies which are useful for researchers within different 
culture, with knowledge to promote risk of bias tools in diverse settings. All these will 
result in an increased appropriate use of risk of bias tools, and a consequent increase 
in the quality of evidence in nursing practice. 
 
Strengths and Limitations 
To the best of our knowledge, this is the first study examining the application of 
risk of bias tools in SRs in the field of nursing. The evidence will influence the 
application of risk of bias assessment instruments in SRs of nursing.  
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We included only those SRs of nursing interventions published in Chinese 
journals, possibly limiting the generalizability of the findings to an international 
setting. We were not able to include any grey literature. Also, our study relied on 
reporting from authors, and it is possible that those authors conducted their SRs but 
omitted some important details from their reports, or peer-review processes might 
have resulted in the removal of key information. In addition, we did not examine the 
reliability of any of risk of bias tools.  
 
CONCLUSION 
The risk of bias tool is a new, Cochrane recommended approach to assessing the 
internal validity of RCTs. This study demonstrates that the assessment of risk of bias 
in Chinese nursing SRs are usually either lacking or incomplete, potentially producing 
misleading results. This is also the case in other countries. Health care workers need 
to know that the information they read is reliable and can be applied in practice. This 
study calls on reviewers to promote the application of the Cochrane risk of bias tool 
for assessing individual studies included in SRs, thereby gaining valuable evidence 
for clinical practice. In the future, gaps in quality assessment of SRs should be 
investigated. We expect that the recommendations contained in this study will move 
evidence-based nursing ahead in ways that will bring benefit to health care systems 
and the people they serve. 
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  Table 1. Descriptive characteristics of included SRs. 
Category Characteristic Number (%) of 
N = 208 
Title Systematic review 55 (26.4) 
 
Meta-analysis 142 (68.3) 
 
Other 11 (5.3) 
Focus of reviews Psychological intervention a 18 (8.6) 
 
Health education b 32 (15.4) 
 
Nursing skills c 158 (76.0) 
Indexed in CSCD d Yes 35 (16.8) 
Number of included studies  1-41, median:11  
Condition focused on in 
review(Common ICD-10e) 
Diseases of the circulatory system 45 (21.6) 
 
Pregnancy, childbirth and the puerperium 35 (16.8) 
 
Endocrine, nutritional and metabolic diseases 26 (12.5) 
 
Diseases of the respiratory system 22 (10.6) 
 
Neoplasm 19 (9.1) 
 
Diseases of the skin and subcutaneous tissue 16 (7.7) 
 
Diseases of the digestive system 14 (6.7) 
 
Diseases of the nervous system 12 (5.8) 
 
Diseases of the genitourinary system 10 (4.8) 
 
Diseases of the musculoskeletal system and 
connective tissue 
8 (3.8) 
 
Diseases of the eye and adnexa 4 (1.9) 
 
Mental and behavioral disorders 2 (1.0) 
 
Diseases of the blood and blood-forming organs 
and immune mechanism 
2 (1.0) 
Funding source The number of reviews with funding source(s) 27 (20.6) 
 
Declarations of conflict of interest 0 (0) 
 
The number of funding sources 
Median (IQR) 
Median:0.2  
(range: 0–2) 
Update of a previous review  0 (0) 
aPsychological intervention: Psychological or mental health support provided by nurses.  
bHealth education: Education program to particular patients provided by nurses, such as activities 
of daily living, how to take medicine, etcetera. 
cNursing skills: Nursing care technology for particular patients.  
dCSCD: Chinese Science Citation Database. 
eCommon ICD-10: International Classification of Diseases 10. 
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Table 2. Risk of bias tools used 
Assessment tools Overall 
(n=208)(%) 
2004–2008
(n=23) (%) 
2009–2012  
(n=185) (%) 
X2 P 
Cochrane Handbook 91 (43.7) 9 (39.1) 82 (44.3) 0.152 >0.05 
  Cochrane Handbook version 4 21 (10.1) 2 (8.7) 19 (10.3) 0.007 >0.05 
  Cochrane Handbook version 5 23 (11.0) 0 (0) 23 (12.4) 5.316 <0.05 
  Cochrane Handbook (version not 
specified) 
47 (22.6) 7 (30.4) 40 (21.6) 0.897 >0.05 
Jadad scale 68 (32.7) 9 (39.1) 59 (31.9) 0.768 >0.05 
QUADASa 3 (1.4) 1 (4.3) 2 (1.1) 1.012 >0.05 
Oxford CASPb 4 (1.9) 0 (0) 4 (2.2) 0.433 >0.05 
No mention of assessment tool 19 (9.1) 2 (8.7) 17 (9.2) 0.156 >0.05 
Study quality not assessed 24 (11.5) 3 (13) 21 (11.3) 0.162 >0.05 
aQUADAS: Quality Assessment of Diagnostic Accuracy Studies. 
bCASP: Critical Appraisal Skill Program. 
 
Table 3. Comparing of risk of bias tools used in different studies.  
Assessment tools Reviews in 
this study 
(n=208) 
Reviews in 
Liu’s 
study[31] 
(n=105)  
Cochrane reviews 
in Hopewell’s 
study[21] (n=100)  
Non-Cochran
e reviews in 
Hopewell’s 
study[21] 
(n=100)  
Cochrane risk of bias tool 91 (43.7%) 63 (60%) 95 (95%) 27 (27%) 
Jadad scale 68 (32.7%) 52 (49.5%) 7 (7%) 19 (19%) 
No mention of assessment tool 19 (9.1%) 9 (8.7%) 0 27 (27%) 
 
Table 4. Reporting of the six domains in the Cochrane risk of bias tool in SRs. 
Risk of bias tool’s domains Overall 
(n=208) (%) 
2004-2008 
(n=23) (%) 
2009-2015  
(n=185) (%) 
X2 P 
Sequence generation 153 (73.5) 15 (65.2) 138 (74.6) 1.947 >0.05 
Allocation concealment 130 (62.5) 12 (52.2) 118 (63.8) 1.514 >0.05 
Blinding 145 (69.7) 13 (56.5) 132 (71.3) 2.057 >0.05 
Blinding participants 15 (7.2) 1 (4.3) 14 (10.6) 2.891 >0.05 
Blinding healthcare providers 4 (1.9) 0 (0) 4 (3.0) 2.936 >0.05 
Blinding outcome assessors 16 (7.7) 2 (8.7) 14 (10.6) 2.803 >0.05 
Blinding both participants and 
healthcare providers 
18 (8.6) 4 (4.3) 14 (10.6) 2.894 >0.05 
Incomplete outcome data 126 (60.6) 12 (52.2) 114 (61.6) 0.861 >0.05 
Loss of follow-up 82 (39.4) 12 (52.2) 70 (61.4) 0.887 >0.05 
Intention-to-treat (ITT) analysis 33 (15.9) 5 (21.7) 28 (24.6) 0.768 >0.05 
Selective outcome reporting 17 (8.2) 0 (0) 17 (9.2) 2.325 >0.05 
Other potential sources of bias 25 (12.0) 3 (13) 22 (11.9) 0.018 >0.05 
Using risk of bias graph/summary 4 (1.9) 0 (0) 4 (2.2) 0.433 >0.05 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
26 
 
Table 5. Comparing of the six domains reported in the different studies. 
Risk of bias tool’s domains Reviews 
published 
after 2008 in 
this study 
(n=185)(%) 
Reviews 
published 
after 2008 in 
Liu’s 
study[31] 
(n=69) (%) 
Cochrane 
reviews in 
Hopewell’s 
study[21] 
(n=100) (%) 
Non-Cochrane 
reviews in 
Hopewell’s 
study[21] 
(n=100) (%) 
Sequence generation 138 (74.6) 67 ( 97.1 ) 100 (100) 62 (62) 
Allocation concealment 118 (63.8) 56 (81.1 ) 100 (100) 60 (60) 
Blinding 132 (71.3) 68 (98.5 ) 99 (99) 69 (69) 
Blinding outcome assessors 14 (10.6) 2 (2.9) 42 (42) 24 (24) 
Blinding both participants and 
healthcare providers 
14 (10.6)  38 (38) 18 (18) 
Incomplete outcome data 114 (61.6) 8 (11.6) 95 (95) 61 (61) 
Selective outcome reporting 17 (9.2) 4 (5.8) 86 (86) 20 (20) 
Other potential sources of bias 22 (11.9) 4 (5.8) 86 (86) 29 (29) 
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Table 6. Comparing of various tools for assessment of RCT. 
Name  Years 
developed 
No. of 
Scalea 
No. of 
Checklistb 
Domainc Scope 
used 
Assessment 
focused 
Advantages Disadvantages 
Cochrane 
RoB 
2005   6 RCT Risk of bias It is a domain-based evaluation, in 
which critical assessments are made 
separately for different domains,it is 
based on actual conducting rather 
than reporting. 
 
CASP 1993  11  RCT  Quality of 
study 
recommended for new researchers 
and those who wish to have quick, 
simple, and easy-to-understand tools 
for answering common questions. 
The checklist is based on reporting 
quality rather than actual RCT conduct 
Jadad 1996 3   RCT Quality of 
study 
Simple,easy to use 
 
1.The scale is based on reporting quality 
rather than actual RCT conduct.2.It 
focuses on randomization, double 
blinding, withdrawals or dropouts, and 
these criteria are insufficient to assess the 
internal validity of RCTs. 3.The scale 
tends to overestimate treatment effects 
because it ignores allocation concealment 
which are very important to overall 
assessment of RoB. 
QUADAS 2003  14  Studi
es of 
diagn
ostic 
Quality of 
study 
The checklist provides an efficient, 
comprehensive, convenient tool for 
quality evaluation of systematic 
review of diagnostic research.  
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accur
acy 
especially when assess anew 
methods for disease diagnosis value. 
a
 Scales, in which various components of quality are scored and combined to give a summary score. 
b
 Checklists, in which specific questions are asked. 
C
 Domains,in which critical assessments are made separately for different domains. 
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Fig 1. Search strategy 
Chinese Biomedicine Literature 
Database(CBM)  
http://sinomed.imicams.ac.cn/index.jsp 
#1 Systematic review/exp 
#2 Systematic review 
#3 Meta analysis/exp 
#4 Meta analysis 
#5 #1 or #2 or #3 or #4 
#6 Nursing intervention/exp 
#7 Nursing intervention  
#8 Nursing 
#9 Nurse 
#10 #6 or #7 or #8 or #9  
#11 #5 and #10 
 
Chinese Scientific Journal Full-text Database 
(CSJD)  
http://www.cnki.net/ 
#1 Systematic review 
#2 Meta analysis 
#3 #1 or #2 
#4 Nursing intervention  
#5 Nursing 
#6 Nurse 
#7 #4 or #5 or #6  
#8#3 and #7 
 
Chinese Journal Full-text Database 
(CJFD) 
http://www.cqvip.com/ 
#1 Systematic review 
#2 Meta analysis 
#3 #1 or #2 
#4 Nursing intervention  
#5 Nursing 
#6 Nurse 
#7 #4 or #5 or #6  
#8#3 and #7 
Wanfang Database  
http://www.wanfangdata.com.cn/ 
#1 Systematic review 
#2 Meta analysis 
#3 #1 or #2 
#4 Nursing intervention  
#5 Nursing 
#6 Nurse 
#7 #4 or #5 or #6  
#8#3 and #7 
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●Continuing education activities for nursing reviewers regarding EBN knowledge, 
skills of conducting SRs, and how to implement the risk of bias tools properly 
according to the latest Cochrane Collaboration Handbook versions are needed. 
●Encourage nurses to following CONSORT guidelines in reporting of RCTs. 
●Journals should have quality/risk of bias assessment requirements for submissions. 
●Compare and test the efficacy of various of tools in assessing risk of bias of 
individual studies in nursing SRs is needed.  
